IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-58753-y.html
   My bibliography  Save this article

LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers

Author

Listed:
  • Chendi Li

    (Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital and Harvard Medical School)

  • Mohammed Usman Syed

    (Massachusetts General Hospital Cancer Center)

  • Anahita Nimbalkar

    (Massachusetts General Hospital Cancer Center)

  • Yi Shen

    (Massachusetts General Hospital Cancer Center)

  • Melissa D. Vieira

    (Massachusetts General Hospital Cancer Center)

  • Cameron Fraser

    (Harvard T.H. Chan School of Public Health
    Harvard T.H. Chan School of Public Health)

  • Zintis Inde

    (Harvard T.H. Chan School of Public Health
    Harvard T.H. Chan School of Public Health)

  • Xingping Qin

    (Harvard T.H. Chan School of Public Health
    Harvard T.H. Chan School of Public Health)

  • Jian Ouyang

    (Massachusetts General Hospital Cancer Center
    Medical University of South Carolina)

  • Johannes Kreuzer

    (Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital and Harvard Medical School)

  • Sarah E. Clark

    (Massachusetts General Hospital Cancer Center)

  • Grace Kelley

    (Massachusetts General Hospital Cancer Center)

  • Emily M. Hensley

    (Massachusetts General Hospital Cancer Center)

  • Robert Morris

    (Massachusetts General Hospital Cancer Center)

  • Raul Lazaro

    (Amgen Inc.)

  • Brian Belmonte

    (Amgen Inc.)

  • Audris Oh

    (Massachusetts General Hospital Cancer Center)

  • Makeba Walcott

    (Massachusetts General Hospital Cancer Center)

  • Christopher S. Nabel

    (Massachusetts General Hospital Cancer Center
    Massachusetts Institute of Technology)

  • Sean Caenepeel

    (Amgen Inc.)

  • Anne Y. Saiki

    (Amgen Inc.)

  • Karen Rex

    (Amgen Inc.)

  • J. Russell Lipford

    (Amgen Inc.)

  • Rebecca S. Heist

    (Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital and Harvard Medical School)

  • Jessica J. Lin

    (Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital and Harvard Medical School)

  • Wilhelm Haas

    (Massachusetts General Hospital Cancer Center)

  • Kristopher Sarosiek

    (Harvard T.H. Chan School of Public Health
    Harvard T.H. Chan School of Public Health
    Harvard Medical School)

  • Paul E. Hughes

    (Amgen Inc.)

  • Aaron N. Hata

    (Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital and Harvard Medical School)

Abstract

The efficacy of molecularly targeted therapies may be limited by co-occurring mutations within a tumor. Conversely, these alterations may confer collateral vulnerabilities that can be therapeutically leveraged. KRAS-mutant lung cancers are distinguished by recurrent loss of the tumor suppressor STK11/LKB1. Whether LKB1 modulates cellular responses to therapeutic stress seems unknown. Here we show that in LKB1-deficient KRAS-mutant lung cancer cells, inhibition of KRAS or its downstream effector MEK leads to hyperactivation of JNK due to loss of NUAK-mediated PP1B phosphatase activity. JNK-mediated inhibitory phosphorylation of BCL-XL rewires apoptotic dependencies, rendering LKB1-deficient cells vulnerable to MCL-1 inhibition. These results uncover an unknown role for LKB1 in regulating stress signaling and mitochondrial apoptosis independent of its tumor suppressor activity mediated by AMPK and SIK. Additionally, our study reveals a therapy-induced vulnerability in LKB1-deficient KRAS-mutant lung cancers that could be exploited as a genotype-informed strategy to improve the efficacy of KRAS-targeted therapies.

Suggested Citation

  • Chendi Li & Mohammed Usman Syed & Anahita Nimbalkar & Yi Shen & Melissa D. Vieira & Cameron Fraser & Zintis Inde & Xingping Qin & Jian Ouyang & Johannes Kreuzer & Sarah E. Clark & Grace Kelley & Emily, 2025. "LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers," Nature Communications, Nature, vol. 16(1), pages 1-16, December.
  • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58753-y
    DOI: 10.1038/s41467-025-58753-y
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-58753-y
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-025-58753-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Hongbin Ji & Matthew R. Ramsey & D. Neil Hayes & Cheng Fan & Kate McNamara & Piotr Kozlowski & Chad Torrice & Michael C. Wu & Takeshi Shimamura & Samanthi A. Perera & Mei-Chih Liang & Dongpo Cai & Geo, 2007. "LKB1 modulates lung cancer differentiation and metastasis," Nature, Nature, vol. 448(7155), pages 807-810, August.
    2. Christopher W. Murray & Jennifer J. Brady & Mingqi Han & Hongchen Cai & Min K. Tsai & Sarah E. Pierce & Ran Cheng & Janos Demeter & David M. Feldser & Peter K. Jackson & David B. Shackelford & Monte M, 2022. "LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    3. Ferdinandos Skoulidis & Haniel A. Araujo & Minh Truong Do & Yu Qian & Xin Sun & Ana Galan Cobo & John T. Le & Meagan Montesion & Rachael Palmer & Nadine Jahchan & Joseph M. Juan & Chengyin Min & Yi Yu, 2024. "CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors," Nature, Nature, vol. 635(8038), pages 462-471, November.
    4. Jude Canon & Karen Rex & Anne Y. Saiki & Christopher Mohr & Keegan Cooke & Dhanashri Bagal & Kevin Gaida & Tyler Holt & Charles G. Knutson & Neelima Koppada & Brian A. Lanman & Jonathan Werner & Aaron, 2019. "The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity," Nature, Nature, vol. 575(7781), pages 217-223, November.
    5. Haikuo Zhang & Christine Fillmore Brainson & Shohei Koyama & Amanda J. Redig & Ting Chen & Shuai Li & Manav Gupta & Carolina Garcia-de-Alba & Margherita Paschini & Grit S. Herter-Sprie & Gang Lu & Xin, 2017. "Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2," Nature Communications, Nature, vol. 8(1), pages 1-15, April.
    6. Daisuke Nakada & Thomas L. Saunders & Sean J. Morrison, 2010. "Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells," Nature, Nature, vol. 468(7324), pages 653-658, December.
    7. Haikuo Zhang & Christine Fillmore Brainson & Shohei Koyama & Amanda J. Redig & Ting Chen & Shuai Li & Manav Gupta & Carolina Garcia-de-Alba & Margherita Paschini & Grit S. Herter-Sprie & Gang Lu & Xin, 2017. "Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2," Nature Communications, Nature, vol. 8(1), pages 1-1, August.
    8. András Kotschy & Zoltán Szlavik & James Murray & James Davidson & Ana Leticia Maragno & Gaëtane Le Toumelin-Braizat & Maïa Chanrion & Gemma L. Kelly & Jia-Nan Gong & Donia M. Moujalled & Alain Bruno &, 2016. "The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models," Nature, Nature, vol. 538(7626), pages 477-482, October.
    9. Sang-Min Jeon & Navdeep S. Chandel & Nissim Hay, 2012. "AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress," Nature, Nature, vol. 485(7400), pages 661-665, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Fan Chen & Aria L. Byrd & Jinpeng Liu & Robert M. Flight & Tanner J. DuCote & Kassandra J. Naughton & Xiulong Song & Abigail R. Edgin & Alexsandr Lukyanchuk & Danielle T. Dixon & Christian M. Gosser &, 2023. "Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    2. Taijin Lan & Sara Arastu & Jarrick Lam & Hyungsin Kim & Wenping Wang & Samuel Wang & Vrushank Bhatt & Eduardo Cararo Lopes & Zhixian Hu & Michael Sun & Xuefei Luo & Jonathan M. Ghergurovich & Xiaoyang, 2024. "Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancer," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    3. Lindsey R. Conroy & Harrison A. Clarke & Derek B. Allison & Samuel Santos Valenca & Qi Sun & Tara R. Hawkinson & Lyndsay E. A. Young & Juanita E. Ferreira & Autumn V. Hammonds & Jaclyn B. Dunne & Robe, 2023. "Spatial metabolomics reveals glycogen as an actionable target for pulmonary fibrosis," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    4. Yong Yi & Guoqiang Wang & Wenhua Zhang & Shuhan Yu & Junjie Fei & Tingting An & Jianqiao Yi & Fengtian Li & Ting Huang & Jian Yang & Mengmeng Niu & Yang Wang & Chuan Xu & Zhi-Xiong Jim Xiao, 2025. "Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation," Nature Communications, Nature, vol. 16(1), pages 1-16, December.
    5. Ipshita Nandi & Linjia Ji & Harvey W. Smith & Daina Avizonis & Vasilios Papavasiliou & Cynthia Lavoie & Alain Pacis & Sherif Attalla & Virginie Sanguin-Gendreau & William J. Muller, 2024. "Targeting fatty acid oxidation enhances response to HER2-targeted therapy," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    6. Andrea Lopez & Denis E. Reyna & Nadege Gitego & Felix Kopp & Hua Zhou & Miguel A. Miranda-Roman & Lars Ulrik Nordstrøm & Swathi-Rao Narayanagari & Ping Chi & Eduardo Vilar & Aristotelis Tsirigos & Evr, 2022. "Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    7. Xiangguo Shi & Minhua Li & Zian Liu & Jonathan Tiessen & Yuan Li & Jing Zhou & Yudan Zhu & Swetha Mahesula & Qing Ding & Lin Tan & Mengdie Feng & Yuki Kageyama & Yusuke Hara & Jacob J. Tao & Xuan Luo , 2025. "Guanine nucleotide biosynthesis blockade impairs MLL complex formation and sensitizes leukemias to menin inhibition," Nature Communications, Nature, vol. 16(1), pages 1-20, December.
    8. Jaskaren Kohli & Chen Ge & Eleni Fitsiou & Miriam Doepner & Simone M. Brandenburg & William J. Faller & Todd W. Ridky & Marco Demaria, 2022. "Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    9. Jayaraman, K. & Paramasivan, Lavinsaa & Kiumarsi, Shaian, 2017. "Reasons for low penetration on the purchase of photovoltaic (PV) panel system among Malaysian landed property owners," Renewable and Sustainable Energy Reviews, Elsevier, vol. 80(C), pages 562-571.
    10. Ella N. Hoogenboezem & Shrusti S. Patel & Justin H. Lo & Ashley B. Cavnar & Lauren M. Babb & Nora Francini & Eva F. Gbur & Prarthana Patil & Juan M. Colazo & Danielle L. Michell & Violeta M. Sanchez &, 2024. "Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    11. Ji-Man Park & Da-Hye Lee & Do-Hyung Kim, 2023. "Redefining the role of AMPK in autophagy and the energy stress response," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    12. Shizhong Ke & Fabin Dang & Lin Wang & Jia-Yun Chen & Mandar T. Naik & Wenxue Li & Abhishek Thavamani & Nami Kim & Nandita M. Naik & Huaxiu Sui & Wei Tang & Chenxi Qiu & Kazuhiro Koikawa & Felipe Batal, 2024. "Reciprocal antagonism of PIN1-APC/CCDH1 governs mitotic protein stability and cell cycle entry," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
    13. Biaobin Jiang & Quanhua Mu & Fufang Qiu & Xuefeng Li & Weiqi Xu & Jun Yu & Weilun Fu & Yong Cao & Jiguang Wang, 2021. "Machine learning of genomic features in organotropic metastases stratifies progression risk of primary tumors," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    14. Caterina Bartolacci & Cristina Andreani & Gonçalo Vale & Stefano Berto & Margherita Melegari & Anna Colleen Crouch & Dodge L. Baluya & George Kemble & Kurt Hodges & Jacqueline Starrett & Katerina Poli, 2022. "Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    15. Wei Liu & Hongchao Cao & Jing Wang & Areeg Elmusrati & Bing Han & Wei Chen & Ping Zhou & Xiyao Li & Stephen Keysar & Antonio Jimeno & Cun-Yu Wang, 2024. "Histone-methyltransferase KMT2D deficiency impairs the Fanconi anemia/BRCA pathway upon glycolytic inhibition in squamous cell carcinoma," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    16. Kai-Bo Wang & Yushuang Liu & Jinzhu Li & Chengmei Xiao & Yingying Wang & Wei Gu & Yipu Li & Yuan-Zheng Xia & Tingdong Yan & Ming-Hua Yang & Ling-Yi Kong, 2022. "Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    17. Panayiotis Anastasiou & Christopher Moore & Sareena Rana & Mona Tomaschko & Claire E. Pillsbury & Andrea Castro & Jesse Boumelha & Edurne Mugarza & Sophie Carné Trécesson & Ania Mikolajczak & Cristina, 2024. "Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    18. Qiang Zhao & Young-Min Han & Ping Song & Zhixue Liu & Zuyi Yuan & Ming-Hui Zou, 2022. "Endothelial cell-specific expression of serine/threonine kinase 11 modulates dendritic cell differentiation," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    19. Jin-Fei Lin & Ze-Xian Liu & Dong-Liang Chen & Ren-Ze Huang & Fen Cao & Kai Yu & Ting Li & Hai-Yu Mo & Hui Sheng & Zhi-Bing Liang & Kun Liao & Yi Han & Shan-Shan Li & Zhao-Lei Zeng & Song Gao & Huai-Qi, 2025. "Nucleus-translocated GCLM promotes chemoresistance in colorectal cancer through a moonlighting function," Nature Communications, Nature, vol. 16(1), pages 1-18, December.
    20. Md Amin Hossain & Rutali R. Brahme & Brandon C. Miller & Jakal Amin & Marcela Barros & Jaime L. Schneider & Jared R. Auclair & Carla Mattos & Qingping Wang & Nathalie Y. R. Agar & David J. Greenblatt , 2025. "Mass spectrometry methods and mathematical PK/PD model for decision tree-guided covalent drug development," Nature Communications, Nature, vol. 16(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58753-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.